Genetic factors in ovarian carcinoma (Q34109485)

31 July 2017

1 reference

title

Genetic factors in ovarian carcinoma (English)

1 reference

31 July 2017

Li AJ

1

1 reference

31 July 2017

Karlan BY

series ordinal

2

1 reference

31 July 2017

publication date

1 January 2001

1 reference

31 July 2017

published in

Current Oncology Reports

1 reference

31 July 2017

volume

3

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

27-32

1 reference

Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers.

31 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-001-0039-Y

Modulation of c-fms proto-oncogene in an ovarian carcinoma cell line by a hammerhead ribozyme

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-001-0039-Y

Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer.

21 January 2018

1 reference

12 December 2020

Correlation of TP53 mutations and p53 expression in ovarian tumors

1 reference

12 December 2020

Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene

1 reference

12 December 2020

Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer

1 reference

12 December 2020

Mutation of the PTEN tumor suppressor gene is not a feature of ovarian cancers

1 reference

12 December 2020

Identification of two candidate tumor suppressor genes on chromosome 17p13.3

1 reference

12 December 2020

NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas

1 reference

12 December 2020

Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas

1 reference

12 December 2020

Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations

1 reference

12 December 2020

Increased frequency ofTP53 mutations inBRCA1 andBRCA2 ovarian tumours

1 reference

12 December 2020

Anti-HER2 antibody and heregulin suppress growth of HER2-overexpressing human breast cancer cells through different mechanisms

1 reference

12 December 2020

Comparison of mutations of Ki-RAS and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors

1 reference

12 December 2020

PIK3CA is implicated as an oncogene in ovarian cancer.

1 reference

12 December 2020

Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignancies

1 reference

12 December 2020

Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation

1 reference

12 December 2020

A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening

1 reference

12 December 2020

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

12 December 2020

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

1 reference

12 December 2020

Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers

1 reference

12 December 2020

Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumors

1 reference

12 December 2020

Apoptosis induced by overexpression of hMSH2 or hMLH1.

1 reference

12 December 2020

Growth suppression of human ovarian cancer cells by adenovirus-mediated transfer of the PTEN gene

1 reference

12 December 2020

Allelic imbalance and mutations of the PTEN gene in ovarian cancer

1 reference

12 December 2020

BRCA1 Inhibition of Estrogen Receptor Signaling in Transfected Cells

1 reference

12 December 2020

AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells

1 reference

12 December 2020

DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies

1 reference

12 December 2020

Adenoviral-mediated p53 tumor suppressor gene therapy of human ovarian carcinoma

1 reference

12 December 2020

Growth retardation and tumour inhibition by BRCA1.

1 reference

12 December 2020

DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies

1 reference

12 December 2020

BRCA1 is secreted and exhibits properties of a granin

1 reference

12 December 2020

Expression of OVCA1, a candidate tumor suppressor, is reduced in tumors and inhibits growth of ovarian cancer cells

1 reference

12 December 2020

An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium.

1 reference

12 December 2020

Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone

1 reference

12 December 2020

BRCA1-associated growth arrest is RB-dependent

1 reference

12 December 2020

Genetics and ovarian carcinoma

1 reference

12 December 2020

Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response

1 reference

12 December 2020

Expression of activated rat neu oncogene is sufficient to induce experimental metastasis in 3T3 cells

1 reference

12 December 2020

Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1

1 reference

12 December 2020

10.1007/S11912-001-0039-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1006595102

0 references

1 reference